Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
3.670
-0.070 (-1.87%)
At close: Nov 4, 2024, 4:00 PM
3.490
-0.180 (-4.90%)
After-hours: Nov 4, 2024, 5:08 PM EST

Leap Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1401064528613427
Upgrade
Market Cap Growth
100.66%137.81%-84.43%113.18%395.35%-7.85%
Upgrade
Enterprise Value
6226-331627718
Upgrade
Last Close Price
3.674.144.5032.4022.5011.20
Upgrade
PE Ratio
--1.04-0.93-6.85-3.55-0.76
Upgrade
PS Ratio
---190.7789.49-
Upgrade
PB Ratio
2.131.760.762.652.88-15.49
Upgrade
P/FCF Ratio
-1.50-2.35-0.91-8.14-5.17-1.00
Upgrade
P/OCF Ratio
-1.50-2.42-0.91-8.14-5.17-1.01
Upgrade
EV/Sales Ratio
---107.8051.27-
Upgrade
EV/EBITDA Ratio
-0.32-0.300.60-4.03-2.72-0.55
Upgrade
EV/EBIT Ratio
-0.32-0.300.60-4.02-2.72-0.55
Upgrade
EV/FCF Ratio
-0.41-0.570.67-4.60-2.96-0.68
Upgrade
Debt / Equity Ratio
0.010.000.010.000.01-0.59
Upgrade
Debt / FCF Ratio
-0.01-0.01-0.01-0.01-0.02-0.04
Upgrade
Asset Turnover
---0.020.05-
Upgrade
Quick Ratio
5.085.636.0211.637.070.48
Upgrade
Current Ratio
5.105.646.0511.707.090.50
Upgrade
Return on Equity (ROE)
-80.54%-136.82%-65.48%-52.53%-122.55%-886.08%
Upgrade
Return on Assets (ROA)
-45.62%-75.03%-36.33%-29.17%-57.24%-157.03%
Upgrade
Return on Capital (ROIC)
-53.63%-89.56%-40.73%-32.30%-76.13%-492.77%
Upgrade
Earnings Yield
-42.97%-76.83%-122.52%-14.18%-20.50%-121.41%
Upgrade
FCF Yield
-35.64%-42.60%-110.06%-12.29%-19.34%-99.64%
Upgrade
Buyback Yield / Dilution
-142.56%-80.55%-31.94%-44.66%-162.71%-56.69%
Upgrade
Total Shareholder Return
-142.56%-80.55%-31.94%-44.66%-162.71%-56.69%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.